Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin

Paolo Prandoni, Anthonie W.A. Lensing, Martin H. Prins, Martin Gebel, Akos F. Pap, Martin Homering, Rupert Bauersachs, Jan Beyer-Westendorf, Henri Bounameaux, Alexander T. Cohen, Bruce L. Davidson, Bonno van Bellen, Peter Verhamme, Philip S. Wells, Zhong Yuan, Bennett Levitan, Jeffrey I. Weitz

    Research output: Contribution to journal › Article › peer-review

    11 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science